+ All Categories
Home > Documents > Embolization—Arterial (09)

Embolization—Arterial (09)

Date post: 02-Jan-2017
Category:
Upload: dinhthuy
View: 215 times
Download: 0 times
Share this document with a friend
1
458 pursue additional coding education. The success- ful att endee will: 1. Define the nome nclature and concepts funda- mental to interven ti ona l radiology codin g. 2. Be able to code basic interven tional procedures and evaluation and management (E&M) services. 3. Deve lop a fr amework for improving a practice's coding and billing operations. Coordinator: Richard 1. D w;zak, Jr., MD Wa lter C. Blackham, MS , RT(R) David Sacks, MD CODING AND BILLING (07) Objectives: This program is intended to familia ri ze and update attendees on key coding and billing issues pertaining to interventiona l radiology, so that practice reimbur sement can be maximized and liability minimized. The successful attendee will: 1. Recognize areas of recent change and contro- versy in interventional radiology coding. 2. Be able to code and bill for interventional radi- ology proce dures and evaluation and manage- ment (E&fvl) services. 3. Develop a framework to audit and eva lu ate a practice's coding and billing operations. Coor dinator: Richard L. Duszak, Jr. , ,\.1.D Walter C. Blackham, MS, RT(R) Michael C. Brunner, MD H oward L. Dome, MD David M. Epstein, MD Katharine 1. Krol , MD Timothy P. Murphy, MD CONSCIOUS SEDATION AND PAIN MANAGEMENT (08) Objectives: Upon completion of the workshop, the attendee should be able to: 1. Describe the criteria used in the selection of patients for conscious sedation and the essential elements for monitoring patients during and after the procedure. 2. List the common medications used f or sedation and pain management, including strategies to minimize their adverse effects. 3. List the use of intravenous patient-control1ed analgesic pumps, continuous epidural infusion, and regional anesthesia for pain control during and after interventional procedures. 4. Describe the sedati on of the pediatric patient. 5. Summa ri ze the ]eAHO requirements regarding conscious sedation and advice on their imple- mentation in the imerventi onal suite. Coordinator: Douglas c.B. Redd, MD David M. H ovsepian, MD Ian D. T imms, MD EMBOLIZATION-ARTERIAL (09) Objecti ves: Upon completion of the workshop, the attendee should be able to: 1. Describe principl es of arterial embolotherapy including cho ic e of embo li c age nt s, level and site of embolic material delivery, and means of d ep loying the selected embolic agent. 2. Describe the composi ti on and mechanism of action of various emholic agents. 3. Discuss utili ty and applications of embolo- thera py in vari ous clinical scena ri os including gastrointestinal hemorrhage (both up per and l ower GI bleeding), hemoptysis, trauma cia ll y pelvic), solid organ ble eding du e to tumor or tra uma, obstetrical and gynecological hem- orrhage and tumor devascular ization. 4. Describe "post-embo li zati on syndrome" and its treatment. 5. Li st possible complications of embolotherapy and mea ns to minimize these complications. Coordina[Qr: Jeer Sandhu, lvID John J. Borsa, MD Scott C. Goodwin, MD Robert K. Kerlan, Jr., lvID Riad Salem , MD, MBA Susan M. Weeks, MD EMBOLIZATION-VENOUS (10) Objectives: Upon completion of the workshop , the attendee should be able to: 1. Describe th e applications of embo l ot herapy in- volving the venous system in cluding varicocele therapy, pulmonary AVMs, portal hypertension, and arteriovenous malformations. Coordinator: Ian A. S proat, MD, FRCP James C. Andrews, MO Robert J. Rosen, MD Peter N. Waybill, MD Robert l. White, J r., MD Joseph W. YedJicka , Jr., MD ENDOVASCULAR RADIATION FOR PREVENTION OF RESTENOSIS (11) Objecti ves: Upon completi on of the workshop, the attendee should be ab le to: 1. Outline the ra tionale for using radiation to in- hibit restenosis. 2. Describe types of devices currently be in g use d in clinical investigations of this topic. 3. Descr ib e the dosimetry considerations of the different devices and device-centering issues on small versus large vessels. 4. Discuss the safety issues in endovascular radia- tion delivery. 5. Summarize the current status of clinical tria ls. Coordinator: Pauicia E. Cole, MD, PhD Stephen Balter, PhD Frankli.n J. Miller, Jr. , MD Mahmood K R.navi, MD Mohsin Saeed, MD Ron Waksman, MD GASTROINTESTINAL INTERVENTIONS (12) Objectives: Upon completion of the workshop , the atte nde e sho uld be ab le to:
Transcript
Page 1: Embolization—Arterial (09)

458

pursue additional coding education. The success­ful attendee will:

1. Define the nomenclature and concepts funda­mental to interventional radiology coding.

2. Be able to code basic interventional procedures and evaluation and management (E&M) services.

3. Develop a framework for improving a practice's coding and bill ing operations.

Coordinator: Richard 1. D w;zak, Jr., MD

Walter C. Blackham, MS, RT(R) David Sacks, MD

CODING AND BILLING (07) Objectives: This program is intended to familiarize and update attendees on key coding and billing issues pertaining to interventional radiology, so that practice reimbursement can be maximized and liability minimized. The successful attendee will:

1. Recognize areas of recent change and contro­versy in interventional radiology coding.

2. Be able to code and bill for interventional radi­ology procedures and evaluation and manage­ment (E&fvl) services.

3. Develop a framework to audit and evaluate a practice's coding and billing operations.

Coordinator: Richard L. Duszak, Jr. , ,\.1.D

Walter C. Blackham, MS, RT(R)

Michael C. Brunner, MD

Howard L. Dome, MD

David M. Epstein, MD Katharine 1. Krol , MD

Timothy P. Murphy, MD

CONSCIOUS SEDATION AND PAIN MANAGEMENT (08) Objectives: Upon completion of the workshop, the attendee should be able to:

1. Describe the criteria used in the selection of patients for conscious sedation and the essential elements for monitoring patients during and after the procedure.

2. List the common medications used for sedation and pain management, including strategies to minimize their adverse effects.

3. List the use of intravenous patient-control1ed analgesic pumps, continuous epidural infusion, and regional anesthesia for pain control during and after interventional procedures.

4. Describe the sedation of the pediatric patient. 5. Summarize the ]eAHO requirements regarding

conscious sedation and advice on their imple­mentation in the imerventional suite.

Coordinator: Douglas c.B. Redd, MD

David M. H ovsepian, MD Ian D. T imms, MD

EMBOLIZATION-ARTERIAL (09) Objectives: Upon completion of the workshop, the attendee should be able to:

1. Describe principles of arterial embolotherapy including cho ice of embolic agents, level and site of embolic material delivery, and means of deploying the selected embolic agent.

2. Describe the composi tion and mechanism of action of various emholic agents.

3. Discuss utility and applications of embolo­thera py in various clinical scenarios including gastrointestinal he morrhage (bo th upper and lower GI bleeding), hemoptysis, trauma (espe~ cially pelvic), solid organ bleeding due to tumor or trauma, obstetrical and gynecologica l hem­orrhage and tumor devascularization.

4. Describe "post-embolization syndrome" and its treatment.

5. List possible complications of embolotherapy and means to minimize these complications.

Coordina[Qr: Jeer Sandhu, lvID

John J. Borsa, MD Scott C. Goodwin, MD Robert K. Kerlan, Jr., lvID

Riad Salem, MD, MBA Susan M. Weeks, MD

EMBOLIZATION-VENOUS (10) Objectives: Upon completion of the workshop, the attendee should be able to:

1. Describe the applications of embolotherapy in­volving the venous system including varicocele therapy, pulmonary AVMs, portal hypertension, and arteriovenous malformations.

Coordinator: Ian A. Sproat, MD, FRCP

James C. Andrews, MO Robert J. Rosen, MD Peter N. Waybill, MD

Robert l. White, Jr., MD Joseph W. YedJicka, Jr., MD

ENDOVASCULAR RADIATION FOR PREVENTION OF RESTENOSIS (11) Objectives: Upon completion of the workshop, the attendee should be able to:

1. Outline the ra tionale for using radiation to in­hibit restenosis.

2. Describe types of devices currently being used in clinical investigations of this topic.

3. Describe the dosimetry considerations of the different devices and device-centering issues on small versus large vessels.

4. Discuss the safety issues in endovascular radia­tion delivery.

5. Summarize the current status of clinical trials.

Coordinator: Pauicia E. Cole, MD, PhD

Stephen Balter, PhD

Frankli.n J. Miller, Jr. , MD

Mahmood K R.navi, MD

Mohsin Saeed, MD

Ron Waksman, MD

GASTROINTESTINAL INTERVENTIONS (12) Objectives: Upon completion of the workshop, the attendee should be able to:

Recommended